AI Summary
5 min read🎙️ The Voices & The Context
- The Format: Solo-hosted daily market update podcast, clocking in under 10 minutes with a fast-paced rundown of news, headlines, and fun facts.
- The Key Players: Host: Zayd Mani, delivering energetic solo commentary on markets, stocks, and pop culture crossovers—no guests, just his witty takes on finance news.
- The Vibe: Energetic and educational with a fun, casual edge—mixing hard market analysis with personal asides like pizza reviews and Olympic excitement.
🗝️ Key Themes & Topics
The episode packs in market volatility, corporate battles, merger drama, and light-hearted closers, prepping listeners for the week ahead.
- Topic 1: Tariff Uncertainty – Supreme Court strikes down 60% of Trump's tariffs under IEEPA as illegal, but Trump pivots to 50% across-the-board tariffs via Section 122 for 150 days, planning Section 301/232 follow-ups; markets rally short-term but brace for volatility.
- Topic 2: Obesity Drug Wars – Novo Nordisk's CagriSema flops in trial (20.2% weight loss vs. Eli Lilly's Zepbound at 23.6%), tanking shares 10%+ and 60% yearly; Lilly launches convenient QuickPen at $299/month and eyes GLP-1 pill.
- Topic 3: Netflix-Warner Bros Merger Saga – Deadline for Paramount/Skydance's final offer to WBD ($30/share) vs. Netflix's $27.75/share streaming/movies bid; DOJ probes monopoly risks, Trump demand
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
What you'll learn
- 1 (00:38) **Market Recap and Tariff Updates**
- 2 (02:40) **Novo Nordisk Obesity Drug Setback**
- 3 (04:33) **Netflix-Warner Bros Merger Drama**
- 4 (06:23) **Domino's Strong Quarter**
- 5 (07:39) **Gilead Acquires Arcellix**
- 6 (08:17) **Olympic Gold Medal Value**
+ Full timestamped outline available in the app
Show Notes
Market update for Monday February 23, 2026
Check out the Public app for incredible investing tools and to support the show (LINK)
Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.
In today’s episode:
- Trump’s slaps 15% tariffs after Supreme Court ruling
- DOJ probes Netflix, James Cameron pushes back on $72B Warner Bros. deal
- Novo Nordisk falls further behind Eli Lilly in the GLP-1 obesity drug race as new trial data disappoints
- Domino’s beats on U.S. sales as value deals win over consumers
- Gilead buys cancer biotech Arcellx for $7.8B
- Fun Fact: Olympic gold medals only have 6g of gold
More from this podcast
The Rundown →